Linaglipton Tablet (Linagliptin)

Adult dosage

The recommended dose of this medication is 5 mg once daily. It can be taken regardless of meals.

This medication should not be used in patients who are allergic to the active ingredient or any other component. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is necessary when used with other drugs that can cause hypoglycemia, such as insulin or sulfonylureas, as the risk of hypoglycemia may increase. Experience with this drug in patients with heart failure is limited, so it should be used cautiously. Acute pancreatitis may occur while taking this medication; therefore, if severe abdominal pain persists, stop taking it immediately and consult a doctor. A skin condition known as bullous pemphigoid may appear, so if blisters or skin irritation occur, inform your doctor immediately. Hypoglycemic symptoms may occur during treatment with this drug, so symptoms should be closely monitored, and appropriate action should be taken if necessary. The safety of this medication has not been established in pregnant women, so its use is not recommended; breastfeeding women should also use it cautiously. This medication is not recommended for children under 10 or adolescents, as safety and efficacy have not been adequately confirmed. Elderly patients may use this drug like general adults, and dosage adjustments are not needed. Patients with diminished kidney or liver function can also use this medication without dosage adjustments. In the case of overdose, the drug remaining in the gastrointestinal tract should be removed, and symptoms should be observed, providing appropriate treatment if necessary. This medication should be kept out of reach of children, and transferring it to other containers should be avoided as it may negatively affect the quality.

Serious side effects

Urticaria, angioedema, pancreatitis, bullous pemphigoid, severe and disabling arthralgia, acute pancreatitis, chest tightness, difficulty breathing, respiratory distress, congestive heart failure, acute myocardial infarction, cardiac arrest, heart failure, acute kidney injury, end-stage kidney disease, sudden and severe headache, seizures, altered consciousness, visual disturbances, paralysis, markedly reduced urine output, severe systemic edema accompanied by elevated blood pressure, severe

Mild side effects

• Hypoglycemia
• hypertriglyceridemia
• hyperlipidemia
• cough
• constipation
• oral ulcer formation
• rash
• severe and disabling arthralgia
• rhabdomyolysis
• weight gain

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Bright red, round, biconvex film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)